News | 2025.03.26
In the face of global health crises and growing public health challenges, strengthening the links between scientific research (both fundamental and applied) and clinical practice has become essential. Recognizing this need, the Institut Pasteur has launched the MD-PhD program as part of its “Pasteur 2030” strategic plan, aiming to engage the Institute in training physician-scientists who can...
News | 2025.03.20
The Institut Pasteur and UCSF-QBI celebrated an ongoing successful scientific collaboration today, which was initiated in March 2019, and expanded significantly during the pandemic. This alliance, formalized in October 2022, aimed at bolstering the fight against infectious diseases, has already spawned more than 20 research projects, a dozen publications in high-level journals, and numerous...
Document de presse | 2025.03.06
In a Nature perspective paper, scientists across Africa, America, Asia, Australia, and Europe outline for the first time how Artificial Intelligence (AI) can transform the landscape of infectious disease research and improve pandemic preparedness. In the next five years, integrating AI into country response systems could save more lives by anticipating the location and trajectory of disease...
Article | 2023.02.23
The new Graduate School "One Health in Emerging Infectious Diseases" (1H-EID) is entirely dedicated to EIDs with a multidisciplinary approach. This Graduate School offers a high-level educational program based on research, to train future researchers, health professionals and decision-makers.The aim of 1H-EID will be to form a community of frontline actors, researchers and decision-makers,all...
Article | 2020.08.13
The main challenge for academics in the commercialization of important new discoveries is the technological development gap: the phase between inventions at an early stage and the stage that innovative technologies must reach to become viable and attractive candidates for licensing and commercialization.For high risk/high value products or for products with low commercial profitability, it is...
Vidéo | 2025.04.04
Meningitis: warning signs!200 cases in France since January? Yes, but... This figure concerns invasive meningococcal infections, a 25-year record. But not all of them are meningitis!Dr Samy Taha, medical researcher at the CNR des Méningocoques, reminds us of the importance of prevention and rapid screening to limit serious forms of the disease.Symptoms to watch out for :High fever and intense...
Vidéo | 2025.04.07
Measles explodes in 2025: what do we do?Nearly 200 cases in France this year, twice as many as last year! This ultra-contagious virus infects the respiratory tract before spreading throughout the body. 1 patient can infect 20 - as easily as a cold! Fever, cough, rash... but above all serious complications for 1 in 5 people: pneumonia, encephalitis, hospitalization, and babies at risk. Over a...
Article | 2025.02.27
Through a partnership between Ludwig Maximilian University (LMU) of Munich and the Institut Pasteur, outstanding medical students can pursue hands-on research in Paris. This unique framework, part of the Institut Pasteur MD-PhD program and the LMU StEP program, enriches clinical training with cutting-edge biomedical research.
News | 2017.05.02
The Search Committee for Director of the Institut Pasteur invites expressions of interest from potential candidates for the position of Director of the Institute. The Search Committee for Director of the Institut Pasteur welcomes letters of interest accompanied by curriculum vitae. Please send all letters and other inquiries by e-mail to searchcommittee2017@pasteur.fr. All...
News | 2017.06.29
WHO adopted in 2016 a global strategy to eliminate hepatitis B and C by 2030. On the basis of anthropological analyses conducted in multiple African countries, a group of researchers, including some from the Institut Pasteur, suggest that to achieve these goals it is essential to improve the communication about viral hepatitis. According to WHO, viral hepatitis caused 1.34 million deaths in...